Press release
01.08.2014 To the attention of healthcare professionals Levonorgestrel and ulipristal remain suitable emergency contraceptives for all women, regardless of bodyweight […]
Important notification
01.08.2014 E-mail communication technical issues solving Following NAMMD e-mail technical issues solving, please be advised that these services are functional […]
Important notification
30.07.2014 E-mail technical issues / Interim NAMMD e-mail addresses Because of technical issues, communication with the NAMMD via @anm.ro e-mail […]
Press release
15.07.2014 To the attention of healthcare professionals EMA press release: PRAC recommends suspension and reformulation of oral methadone solutions containing […]
Press release
15.07.2014 To the attention of healthcare professionals EMA press release: PRAC recommends restricted use of bromocriptine-containing medicinal products download document […]
Important notification
27.06.2013 To the attention of all authorised wholesale distributors of medicinal products Please be advised that, in accordance with Article […]
Important notification
26.06.2014 To the attention of pharmaceutical companies and insterested persons The NAMMD would like to inform about the organisation in […]
Press release
17.06.2014 To the attention of healthcare professionals EMA starts review of ibuprofen medicines; Review to evaluate cardiovascular risk with high […]
Important notification
12.06.2014 To the attention of Marketing Authorisation Holders Please be advised that, as of 15.06.2014, in addition to the usual […]
Important notification
11.06.2014 To the attention of Marketing Authorisation Holders Please be advised that, in accordance with provisions of Article 2 of […]